Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Ulcer 2Stomach Neoplasms 2Thoracic Diseases 1Overweight 1Obesity 1Lung Neoplasms 1Liver Neoplasms 1Intestinal Polyps 1Intestinal Neoplasms 1

Interventions

Irinotecan 8Bevacizumab 8Fluorouracil 7Leucovorin 6Oxaliplatin 5Capecitabine 4Drug Therapy 3Cetuximab 35,10-methylenetetrahydrofolic acid 3Radiotherapy 2Levoleucovorin 2Folfox protocol 2Colonoscopy 2Bisacodyl 2Aspirin 2Artesunate 2trametinib 1spartalizumab 1repotrectinib 1pralsetinib 1pembrolizumab 1nazartinib 1napabucasin 1lutetium Lu 177 dotatate 1guadecitabine 1encorafenib 1copper dotatate CU-64 1canakinumab 1camrelizumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Neoplasms × (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol × Clear all
NCT05517408 2023-08-16

Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.

RenJi Hospital

Phase NA Unknown
30 enrolled
Gastrointestinal

Intestinal Neoplasms, Intestinal Polyps, Stomach Neoplasms, Stomach Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡